Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
SENSEX NIFTY

Parabolic Drugs Ltd.

BSE: 533211 | NSE: PARABDRUGS | ISIN: INE618H01016 | SECTOR: PHARMACEUTICALS |
OR
Add to Watchist
Have you invested in these stocks? You can track them better in your Portfolio
LIVE
BSE
Jan 19, 16:00
8.01
0.16 (+2.04%)
VOLUME 3,505
AVERAGE VOLUME
5-Day 31,158
10-Day 27,088
30-Day 19,814
VOLUME SHOCKER
5-Day 31,158
10-Day 27,088
30-Day 19,814
Prev. Close
7.85
Open Price
8.15
Bid PRICE (QTY.)
8.01 (500)
Offer PRICE (Qty.)
8.15 (100)
VWAP 7.96
Market
Depth

Market Depth (20 Jan 2018)

BUY SELL
QTY PRICE PRICE QTY
500 8.01 8.10 600
600 8.00 8.15 120
500 7.96 8.20 250
755 7.95 8.22 150
606 7.92 8.23 100
8940 Total 5300 Total

Buy Qty

8940

Sell QTY

5300

Today's Low/High 7.91 8.15
52 Wk Low/High 6.02 10.39
L/U Price Band 7.46 8.24
LIVE
NSE
Jan 19, 15:40
8.00
0.05 (+0.63%)
VOLUME 15,767
AVERAGE VOLUME
5-Day 32,241
10-Day 49,207
30-Day 39,469
VOLUME SHOCKER
5-Day 32,241
10-Day 49,207
30-Day 39,469
Prev. Close
7.95
Open Price
7.85
Bid PRICE (QTY.)
8.00 (500)
Offer PRICE (Qty.)
0.00 (0)
VWAP 8.12
Today's Low/High 7.85 8.25
52 Wk Low/High 5.50 12.00
L/U Price Band 7.60 8.30
Action in Parabolic Drugs

No recommendations so far.

What's your call on Parabolic Drugs today?
Read 10 investor views

Consolidated
MARKET CAP (Rs Cr)
49.58
P/E
-
BOOK VALUE (Rs)
-133.10
DIV (%)
0.00%
Market Lot
1
INDUSTRY P/E
31.06
EPS (TTM)
* -
P/C
-
PRICE/BOOK
-
DIV YIELD.(%)
-%
FACE VALUE (Rs)
10.00
DELIVERABLES (%)
100 new
DELIVERY AVERAGES
3-Day 0.00%
5-Day 0.00%
8-Day 0.00%
* Note - Trailing EPS is displayed only when latest 4 quarter results are available.
Track Parabolic Drugs on the go with the moneycontrol app
Also available for
EXPAND ALL COLLAPSE ALL

Top Trading Ideas

21 November 2017

buy

BajajFinance Nov Fut

Entry Price (Rs)

1,792.00

Exit Price (Rs)

1,822.00

Gain (Rs)

30.00

buy

TataSteel Nov Fut

Entry Price (Rs)

701.20

Exit Price (Rs)

712.00

Gain (Rs)

11.00

buy

TitanCompany Nov Fut

Entry Price (Rs)

803.40

Exit Price (Rs)

810.20

Gain (Rs)

7.00

buy

Wockhardt Nov Fut

Entry Price (Rs)

732.80

Exit Price (Rs)

748.00

Gain (Rs)

15.00

buy

DATAM GLOB Nov Fut

Entry Price (Rs)

128.40

Exit Price (Rs)

135.50

Gain (Rs)

8.00

buy

MaxFinancial Nov Fut

Entry Price (Rs)

570.00

Exit Price (Rs)

580.50

Gain (Rs)

11.00

Historic Prices & Simple Moving Averages
on
1 week  |  1 month  |  3 month  |  1 year  |  2 year
  1 Year Current %Gain / Loss
Open Price 9.62 8.15  
High Price 10.04 8.15  
Low Price 9.55 7.91  
Last Price 9.89 8.01 -19.01
Volume 44,487 3,505 -92.12
Simple Moving Averages
Days BSE NSE
30 8.36 8.37
50 8.52 8.49
150 7.81 7.86
200 7.86 7.90

Get Historical Stock Prices »

Click here to view the Open, High, Low, Close, Volume and Spread data for Parabolic Drugs

News/Videos & Announcements
Stock Advice & Research Reports
News Across the Web
Financials
Income Statement
 Standalone Sep'17 Jun'17 Mar'17
Dec'16
Net Sales 23.96 15.33 19.89 24.26
Other Income 0.34 0.00 0.00 0.00
PBDIT -3.67 -0.96 -10.98 1.26
Net Profit -14.23 -12.62 57.75 -45.39

Annual Report

Download in PDF format 2017 |2016 |2015 |2014 |2013 |2012 |2011 |2010
Balance Sheet
Mar'17
(In Rs Cr)
Total Share Capital 61.89
Net Worth -789.33
Total Debt 979.46
Net Block 348.84
Investments 6.33
Total Assets 190.14
Peers
Peer Comparison
Company Name Last Price %
Change
52 wk
High
52 wk
Low
Market Cap
Sun Pharma 572.00 -0.74 728.45 433.15 137,240.49
Cipla 602.05 -0.19 663.00 479.00 48,464.73
Piramal Enter 2794.55 0.92 3083.05 1670.00 48,223.62
Cadila Health 441.50 1.24 558.00 334.35 45,198.24
Lupin 923.00 0.50 1572.25 807.00 41,680.55
More » 
Share Holding Pattern & Mutual Funds Holding
Share Holding Pattern in (%)
 Jun' 17Mar' 17Dec' 16Sep' 16
Promoter37.7937.8037.8038.64
Public (FII + DII)62.2162.2062.2061.36
Others0.000.000.000.00
Total100.00100.00100.00100.00
Mutual Funds Holding
No Mutual Funds Holding the share
Company Information
REGISTERED OFFICE
Address
S.C.O 99-100, Top Floor,,Sector 17 - B,
City
Chandigarh
State
Chandigarh
Pin Code
160017
Tel. No.
0172-3914646 0172-3914647
Fax No.
0172-3914645
REGISTRARS
Name
Link Intime India Pvt. Ltd.
Address
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
City
Mumbai - 400083
State
Maharashtra
Tel. No.
022-49186270, 49186200
Fax No.
022-49186060, 49186195
MANAGEMENT
Name
Designation
Pranav Gupta
Managing Director
Vineet Gupta
Whole Time Director
Sanjeev Kumar
Director
Jagjit Singh Chahal
Director
Vandana Singla
Director
Message Board & Community
Right Time + Right Stock + Right Investment = HIGH PROFIT

Meghmani Organics Recommended on Aug 27th 2017

Recommended price 73.00  |  Peak from reco 129.40 78.11%

For more multi bagger recommendations click here

What are Multi baggers?

Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.

About Parabolic Drugs

Parabolic Drugs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 49.58 crore.

The company management includes Pranav Gupta - Managing Director, Vineet Gupta - Whole Time Director, Sanjeev Kumar - Director, Jagjit Singh Chahal - Director, Vandana Singla - Director.

It is listed on the BSE with a BSE Code of 533211 and the NSE with an NSE Code of PARABDRUGS.

Its Registered office is at S.C.O 99-100, Top Floor,,Sector 17 - B, Chandigarh,Chandigarh - 160017.

Their Registrars are Link Intime India Pvt. Ltd.

Quick Links for Parabolic Drugs
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.
Results of Parabolic Drugs